Otomagnetics Engaged Frontage Laboratories, Inc. For c-GMP Manufacturing of Otomagnetics Magnetic Drug Delivery Formulation

Sunday, June 23, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

The strategic and cost effective engagement between Otomagnetics and Frontage Laboratories is enabling the development of magnetic nanoparticles carrying two drugs for the non-invasive treatment of middle ear infection using Otomagnetics' proprietary magnetic delivery system.

GAITHERSBURG, Md., June 23, 2019 /PRNewswire-PRWeb/ -- Otomagnetics' technology is enabling non-invasive magnetic delivery

to hard to reach targets. In pre-clinical studies the technology has shown drug delivery to the middle ear without tympanostomy tubes or the need to puncture the ear drum. Magnetic delivery to the middle ear may provide a non-invasive treatment for recurrent or chronic child middle ear infections.

The strategic and cost effective engagement between Otomagnetics and Frontage Laboratories is enabling the development of magnetic nanoparticles carrying two drugs for the non-invasive treatment of middle ear infection using Otomagnetics' proprietary magnetic delivery system.

"We are excited about collaborating with a company whose pre-clinical drug development services are exceptional. Engaging with Frontage Laboratories strengthens Otomagnetics' preclinical manufacturing ability, which would facilitate IND enabling studies," says Abhita Batra, CEO of Otomagnetics.

"We are excited to engage Otomagnetics to help manufacture their novel magnetic drug delivery product, which could enable treatment of multiple conditions," says Dr. Song Li, CEO of Frontage Laboratories.

Frontage Laboratories, Inc., is a global full-service Clinical Research Organization with facilities in the US and China. Frontage specializes in research and development (R&D) product development services to pharmaceutical and biotech companies.

Otomagnetics, a Delaware C-Corp and is developing a non-invasive method to deliver drugs and other therapeutic payloads to hard to reach targets in the body, to inner and middle ear compartments, to the eye, and into and through the skin.

 

SOURCE Otomagnetics



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store